Chongqing Xishan Science & Technology Co., Ltd.

SHSE:688576 Stock Report

Market Cap: CN¥3.0b

Chongqing Xishan Science & Technology Past Earnings Performance

Past criteria checks 3/6

Chongqing Xishan Science & Technology has been growing earnings at an average annual rate of 40.5%, while the Medical Equipment industry saw earnings growing at 6.1% annually. Revenues have been growing at an average rate of 23.4% per year. Chongqing Xishan Science & Technology's return on equity is 6.6%, and it has net margins of 33.4%.

Key information

40.5%

Earnings growth rate

38.5%

EPS growth rate

Medical Equipment Industry Growth16.0%
Revenue growth rate23.4%
Return on equity6.6%
Net Margin33.4%
Last Earnings Update30 Sep 2024

Recent past performance updates

Chongqing Xishan Science & Technology's (SHSE:688576) Attractive Earnings Are Not All Good News For Shareholders

Sep 12
Chongqing Xishan Science & Technology's (SHSE:688576) Attractive Earnings Are Not All Good News For Shareholders

Recent updates

Chongqing Xishan Science & Technology's (SHSE:688576) Attractive Earnings Are Not All Good News For Shareholders

Sep 12
Chongqing Xishan Science & Technology's (SHSE:688576) Attractive Earnings Are Not All Good News For Shareholders

Is Chongqing Xishan Science & Technology Co., Ltd. (SHSE:688576) Trading At A 23% Discount?

Aug 22
Is Chongqing Xishan Science & Technology Co., Ltd. (SHSE:688576) Trading At A 23% Discount?

Chongqing Xishan Science & Technology Co., Ltd.'s (SHSE:688576) Popularity With Investors Is Under Threat From Overpricing

Mar 27
Chongqing Xishan Science & Technology Co., Ltd.'s (SHSE:688576) Popularity With Investors Is Under Threat From Overpricing

Revenue & Expenses Breakdown

How Chongqing Xishan Science & Technology makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

SHSE:688576 Revenue, expenses and earnings (CNY Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 2435411812356
30 Jun 2436513012253
31 Mar 2436711912349
31 Dec 2336111711847
30 Sep 233129710138
30 Jun 23298879834
31 Mar 23286888931
31 Dec 22262758530
31 Dec 21209616928
31 Dec 20127145519
31 Dec 1982-546935
30 Jun 1710219650
31 Mar 1710123600
31 Dec 1610126560
30 Sep 167815480
30 Jun 16564410
31 Mar 16491380
31 Dec 1543-2360
31 Dec 1433-7340
31 Dec 1342-1320

Quality Earnings: 688576 has a high level of non-cash earnings.

Growing Profit Margin: 688576's current net profit margins (33.4%) are higher than last year (31%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 688576 has become profitable over the past 5 years, growing earnings by 40.5% per year.

Accelerating Growth: 688576's earnings growth over the past year (22.4%) is below its 5-year average (40.5% per year).

Earnings vs Industry: 688576 earnings growth over the past year (22.4%) exceeded the Medical Equipment industry -8.8%.


Return on Equity

High ROE: 688576's Return on Equity (6.6%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/23 21:19
End of Day Share Price 2024/12/23 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Chongqing Xishan Science & Technology Co., Ltd. is covered by 1 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Mingrui WangEverbright Securities Co. Ltd.